Market Overview

The Global Preimplantation Genetic Testing Market was valued at USD 938.4 million in 2023 and is expected to reach USD 1,698.7 million by 2031 while growing at a CAGR of 7.7% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global preimplantation genetic testing market growth. Preimplantation Genetic Testing (PGT) is conducted on embryos from in vitro fertilization (IVF) to detect genetic or chromosomal abnormalities, aiding in the selection of embryos with the best chance of a successful pregnancy and healthy offspring. Typically, PGT is for couples at risk of hereditary disorders or facing recurrent pregnancy loss.

The growing demand for Assisted Reproductive Technologies (ART) and the ongoing progress in genetic testing, including next-generation sequencing (NGS), microarray analysis, and polymerase chain reaction (PCR), propel the preimplantation genetic testing (PGT) market. Nevertheless, challenges persist in the form of the expenses associated with PGT procedures and the need for enhanced testing accuracy and reliability, which impede market expansion.

Furthermore, the global preimplantation genetic testing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Procedure Analysis

The Global Preimplantation Genetic Testing Market is segmented among PGD, and PGS, based on Procedure. In 2023, PGD accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Product Analysis

The Global Preimplantation Genetic Testing Market is segmented among Reagents and Consumables, Instruments, and Software, based on Product. In 2023, Reagents and Consumables accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Preimplantation Genetic Testing Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are The Cooper Companies Inc., Illumina Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Inc., PerkinElmer Inc., Invitae Corp., Natera Inc., Igenomix Sl, Bioarray SL, and Genea Ltd.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Preimplantation Genetic Testing Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Preimplantation Genetic Testing Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Preimplantation Genetic Testing Market Segmentation, By Procedure

• Global Preimplantation Genetic Testing Market Share Analysis, By Procedure

• Global Preimplantation Genetic Testing Market Growth Analysis, By Procedure

• Global Preimplantation Genetic Testing Market Trends, By Procedure

o Preimplantation Genetic Diagnosis (PGD)

o Preimplantation Genetic Screening (PGS)

6. Global Preimplantation Genetic Testing Market Segmentation, By Product

• Global Preimplantation Genetic Testing Market Share Analysis, By Product

• Global Preimplantation Genetic Testing Market Growth Analysis, By Product

• Global Preimplantation Genetic Testing Market Trends, By Product

o Reagents and Consumables

o Instruments

o Software

7. Global Preimplantation Genetic Testing Market Segmentation, By Technology

• Global Preimplantation Genetic Testing Market Share Analysis, By Technology

• Global Preimplantation Genetic Testing Market Growth Analysis, By Technology

• Global Preimplantation Genetic Testing Market Trends, By Technology

o Next Generation Sequencing (NGS)

o Polymerase Chain Reaction (PCR)

o Fluorescent In-Situ Hybridization (FISH)

o Others

8. Global Preimplantation Genetic Testing Market Segmentation, By Application

• Global Preimplantation Genetic Testing Market Share Analysis, By Application

• Global Preimplantation Genetic Testing Market Growth Analysis, By Application

• Global Preimplantation Genetic Testing Market Trends, By Application

o Chromosomal Abnormalities

o X-linked Diseases

o Embryo Testing

o Aneuploidy Screening

o HLA Typing

o Other Applications

9. Global Preimplantation Genetic Testing Market Segmentation, By End User

• Global Preimplantation Genetic Testing Market Share Analysis, By End User

• Global Preimplantation Genetic Testing Market Growth Analysis, By End User

• Global Preimplantation Genetic Testing Market Trends, By End User

o Fertility Centers

o Hospitals

o Diagnostic Centers

o Research Centers and Academic Labs

10. Global Preimplantation Genetic Testing Market Segmentation, By Region

• Global Preimplantation Genetic Testing Market Share Analysis, By Region

• Global Preimplantation Genetic Testing Market Growth Analysis, By Region

• Global Preimplantation Genetic Testing Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

11. Competitive Landscape

• Quest Diagnostics Incorporated*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Natera, Inc.

• COOPER SURGICAL, INC.

• Genea Pty Limited.

• Invitae Corporation

• Laboratory Corporation of America Holdings

• Thermo Fisher Scientific Inc.

• Bioarray S.L.

• Illumina, Inc.

• Igenomix

• RGI

• F. Hoffmann-La Roche Ltd  

*Similar analysis will be provided for each company listed above.